Petros Pharmaceuticals, Inc. Debt Instrument, Face Amount
Petros Pharmaceuticals, Inc. (PTPI) had Debt Instrument, Face Amount of $10.20 million as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2025-03-31
- 2024-12-31: Debt Instrument, Face Amount $10.20M.
- 2024-09-30: Debt Instrument, Face Amount $10.20M.
- 2024-06-30: Debt Instrument, Face Amount $10.20M.
- 2024-03-31: Debt Instrument, Face Amount $10.20M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2024-12-31 | $10.20M 10-K · filed 2025-03-31 |
| 2024-09-30 | $10.20M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $10.20M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $10.20M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $10.20M 10-K · filed 2024-04-01 |
| 2022-12-31 | $10.20M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |